Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Gelman

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|September 19, 1990
Keeping an open mind about the doses of chemotherapyR S Gelman
Cancer Clinical Trials|January 1, 1981
Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatmentD C Tormey, R S Gelman
Surgery|October 1, 1983
Increased risk of malignancy and uterine disease following perimenarchal hospitalization: an estrogen window effectK K Meyer, R S Gelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearanceR S Gelman, S G Taylor
Hematology/Oncology Clinics of North America|December 1, 1989
Mammography in symptomatic and asymptomatic patientsP C Stomper, R S Gelman
The New England Journal of Medicine|October 14, 1982
Sounding board. Fibrocystic "disease" of the breast--a nondisease?S M Love, R S Gelman, W Silen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Age as a prognostic factor in recurrent breast cancerG Falkson, R S Gelman, F J Pretorius
Cancer Research|July 1, 1984
Dietary seaweed (Laminaria) and mammary carcinogenesis in ratsJ Teas, M L Harbison, R S Gelman
Biometrics|September 1, 1989
A quality-of-life-oriented endpoint for comparing therapiesR D Gelber, R S Gelman, A Goldhirsch
Cancer|October 1, 1990
Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studiesG Falkson, R S Gelman, L Leone, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|September 19, 1990
Keeping an open mind about the doses of chemotherapyR S Gelman
Cancer Clinical Trials|January 1, 1981
Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatmentD C Tormey, R S Gelman
Surgery|October 1, 1983
Increased risk of malignancy and uterine disease following perimenarchal hospitalization: an estrogen window effectK K Meyer, R S Gelman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearanceR S Gelman, S G Taylor
Hematology/Oncology Clinics of North America|December 1, 1989
Mammography in symptomatic and asymptomatic patientsP C Stomper, R S Gelman
The New England Journal of Medicine|October 14, 1982
Sounding board. Fibrocystic "disease" of the breast--a nondisease?S M Love, R S Gelman, W Silen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Age as a prognostic factor in recurrent breast cancerG Falkson, R S Gelman, F J Pretorius
Cancer Research|July 1, 1984
Dietary seaweed (Laminaria) and mammary carcinogenesis in ratsJ Teas, M L Harbison, R S Gelman
Biometrics|September 1, 1989
A quality-of-life-oriented endpoint for comparing therapiesR D Gelber, R S Gelman, A Goldhirsch
Cancer|October 1, 1990
Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studiesG Falkson, R S Gelman, L Leone, et al.
Pageof 5